Instil Bio, Inc. (TIL)
7.58
-0.08
(-1.04%)
USD |
NASDAQ |
Sep 04, 16:00
7.58
0.00 (0.00%)
After-Hours: 20:00
Instil Bio Price to Book Value : 0.4787 for Sept. 4, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 04, 2026 | 0.4787 |
| September 03, 2026 | 0.4838 |
| September 02, 2026 | 0.4854 |
| September 01, 2026 | 0.4857 |
| August 31, 2026 | 0.4806 |
| August 28, 2026 | 0.4787 |
| August 27, 2026 | 0.4964 |
| August 26, 2026 | 0.4945 |
| August 25, 2026 | 0.48 |
| August 24, 2026 | 0.4933 |
| August 21, 2026 | 0.4787 |
| August 20, 2026 | 0.4693 |
| August 19, 2026 | 0.4667 |
| August 18, 2026 | 0.4617 |
| August 17, 2026 | 0.4648 |
| August 14, 2026 | 0.4661 |
| August 13, 2026 | 0.4592 |
| August 12, 2026 | 0.4724 |
| August 11, 2026 | 0.4731 |
| August 10, 2026 | 0.468 |
| August 07, 2026 | 0.468 |
| August 06, 2026 | 0.4598 |
| August 05, 2026 | 0.4585 |
| August 04, 2026 | 0.4579 |
| August 03, 2026 | 0.456 |
| Date | Value |
|---|---|
| July 31, 2026 | 0.4497 |
| July 30, 2026 | 0.451 |
| July 29, 2026 | 0.456 |
| July 28, 2026 | 0.4604 |
| July 27, 2026 | 0.4516 |
| July 24, 2026 | 0.4503 |
| July 23, 2026 | 0.4547 |
| July 22, 2026 | 0.4579 |
| July 21, 2026 | 0.4579 |
| July 20, 2026 | 0.4579 |
| July 17, 2026 | 0.4686 |
| July 16, 2026 | 0.4743 |
| July 15, 2026 | 0.4813 |
| July 14, 2026 | 0.4936 |
| July 13, 2026 | 0.4825 |
| July 10, 2026 | 0.4863 |
| July 09, 2026 | 0.4838 |
| July 08, 2026 | 0.4914 |
| July 07, 2026 | 0.4895 |
| July 06, 2026 | 0.4876 |
| July 02, 2026 | 0.4882 |
| July 01, 2026 | 0.4857 |
| June 30, 2026 | 0.4857 |
| June 29, 2026 | 0.4613 |
| June 26, 2026 | 0.4552 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.691 |
| Alnylam Pharmaceuticals, Inc. | 26.28 |
| Anika Therapeutics, Inc. | 2.029 |
| Savara, Inc. | 7.678 |
| Vericel Corp. | 5.558 |
Price to Book Value Related Metrics
| Price | 7.58 |
| Earnings Yield | -59.00% |
| Market Cap | 51.41M |